
Core Insights - ElastiMed Ltd. has appointed Dr. Amir Belson to its Board of Directors, enhancing its leadership in the wearable medical device sector [1][4] - Dr. Belson brings extensive experience in the medical device industry, having founded and led several successful companies that were acquired by major players [2][3] - His appointment is timely as ElastiMed aims to bring its innovative compression therapy devices to market, targeting millions suffering from lymphatic and venous diseases [3][4] Company Overview - ElastiMed specializes in wearable medical devices designed to treat and manage lymphatic and venous diseases, focusing on innovation and patient empowerment [5] - The company is committed to improving patient outcomes and addressing health equity challenges while enhancing healthcare delivery at home [5][6] - ElastiMed is a portfolio company of The Trendlines Group Ltd. and has received funding from various sources, including the Israeli Innovation Authority and Horizon 2020 [6]